miR615-3p inhibited FBLN1 and osteogenic differentiation of umbilical cord mesenchymal stem cells by associated with YTHDF2 in a m6A-miRNA interaction manner

  • Haoqing Yang 1 ,
  • Wanqing Wang 1 ,
  • Huina Liu 1 ,
  • Chen Zhang 1 ,
  • Yangyang Cao 1 ,
  • Lujue Long 1 ,
  • Xiao Han 2 ,
  • Yuejun Wang 3 ,
  • Fei Yan 4 ,
  • Guoqing Li 2 ,
  • Mengyuan Zhu 1 ,
  • Luyuan Jin , 3 ,
  • Zhipeng Fan , 1,5,6
Expand
  • 1. Laboratory of Molecular Signaling and Stem Cells Therapy, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Beijing, China
  • 2. Jiangsu Province Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China
  • 3. Department of General Dentistry and Integrated Emergency Dental Care, Beijing Stomatological Hospital, Capital Medical University, Beijing, China
  • 4. Xiangya Stomatological Hospital and School of Stomatology, Central South University, Changsha, China
  • 5. Beijing Laboratory of Oral Health, Capital Medical University, Beijing, China
  • 6. Research Unit of Tooth Development and Regeneration, Chinese Academy of Medical Sciences, Beijing, China
sujin_0309@163.com
zpfan@ccmu.edu.cn

Received date: 28 Nov 2023

Revised date: 09 Jan 2024

Accepted date: 27 Jan 2024

Copyright

2024 2024 The Authors. Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.

Abstract

To investigate the role and mechanism of FBLN1 in the osteogenic differentiation and bone regeneration by using umbilical cord mesenchymal stem cells (WJCMSCs). We found that FBLN1 promoted osteogenic differentiation of WJCMSCs and WJCMSC-mediated bone regeneration. It was showed that there was an m6A methylation site in 3′UTR of FBLN1 mRNA, and the mutation of the m6A site enhanced the stability of FBLN1 mRNA, subsequently fostering the FBLN1 enhanced osteogenic differentiation of WJCMSCs. YTHDF2 was identified as capable of recognizing and binding to the m6A site, consequently inducing FBLN1 instability and repressed the osteogenic differentiation of WJCMSCs. Meanwhile, miR-615-3p negatively regulated FBLN1 by binding FBLN1 3′UTR and inhibited the osteogenic differentiation of WJCMSCs and WJCMSC-mediated bone regeneration. Then, we discovered miR-615-3p was found to regulate the functions of FBLN1 facilitated by YTHDF2 through an m6A-miRNA regulation mechanism. We demonstrated that FBLN1 is critical for regulating the osteogenic differentiation potentials of WJCMSCs and have identified that miR615-3p mediated the decay of FBLN1 mRNA which facilitated by m6A reading protein YTHDF2. This provided a novel m6A-miRNA epigenetic regulatory pattern for MSC regulation and bone regeneration.

Cite this article

Haoqing Yang , Wanqing Wang , Huina Liu , Chen Zhang , Yangyang Cao , Lujue Long , Xiao Han , Yuejun Wang , Fei Yan , Guoqing Li , Mengyuan Zhu , Luyuan Jin , Zhipeng Fan . miR615-3p inhibited FBLN1 and osteogenic differentiation of umbilical cord mesenchymal stem cells by associated with YTHDF2 in a m6A-miRNA interaction manner[J]. Cell Proliferation, 2024 , 57(6) : e13607 . DOI: 10.1111/cpr.13607

1
Bunpetch V, Zhang Z-Y, Zhang X, et al. Strategies for MSC expansion and MSC-based microtissue for bone regeneration. Biomaterials. 2019;196:67-79.

DOI

2
Xie Q, Liu R, Jiang J, et al. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? Stem Cell Res Ther. 2020;11:519.

DOI

3
Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci. 2019;76:3323-3348.

DOI

4
Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123:4195-4200.

DOI

5
Chiarugi P, Pani G, Giannoni E, et al. Reactive oxygen species as essential mediators of cell adhesion. J Cell Biol. 2003;161:933-944.

6
Chu M-L, Tsuda T. Fibulins in development and heritable disease. Birth Defects Res C Embryo Today. 2004;72:25-36.

DOI

7
de Vega S, Iwamoto T, Yamada Y. Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci. 2009;66:1890-1902.

DOI

8
Zhu Y, Zhang P, Gu RL, Liu YS, Zhou YS. Origin and clinical applications of neural crest-derived dental stem cells. Chin J Dent Res. 2018;21:89-100.

DOI

9
Sun J-X, Horst OV, Bumgarner R, Lakely B, Somerman MJ, Zhang H. Laser capture microdissection enables cellular and molecular studies of tooth root development. Int J Oral Sci. 2012;4:7-13.

DOI

10
Kobayashi N, Kostka G, Garbe JHO, et al. A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization. J Biol Chem. 2007;282:11805-11816.

DOI

11
Vogel BE, Hedgecock EM. Hemicentin, a conserved extracellular member of the immunoglobulin superfamily, organizes epithelial and other cell attachments into oriented line-shaped junctions. Development. 2001;128:883-894.

DOI

12
Carpten JD, Makalowska I, Robbins CM, Scott N, Trent JM. A 6-mb high-resolution physical and transcription map encompassing the hereditary prostate cancer 1 (HPC1) region. Genomics. 2000;64:1-14.

13
de Vega S, Iwamoto T, Nakamura T, et al. TM14 is a new member of the fibulin family (fibulin-7) that interacts with extracellular matrix molecules and is active for cell binding. J Biol Chem. 2007;282:30878-30888.

DOI

14
Hang Pham LB, Yoo Y-R, Park SH, et al. Investigating the effect of fibulin-1 on the differentiation of human nasal inferior turbinate-derived mesenchymal stem cells into osteoblasts. J Biomed Mater Res A. 2017;105:2291-2298.

DOI

15
Tran H, VanDusen WJ, Argraves WS. The self-association and fibronectin-binding sites of fibulin-1 map to calcium-binding epidermal growth factor-like domains. J Biol Chem. 1997;272:22600-22606.

DOI

16
Fresco VM, Kern CB, Mohammadi M, Twal WO. Fibulin-1 binds to fibroblast growth factor 8 with high affinity: effects on embryo survival. J Biol Chem. 2016;291:18730-18739.

DOI

17
Woeckel VJ, Eijken M, van de Peppel J, Chiba H, van der Eerden BCJ, van Leeuwen JPTM. IFNβ impairs extracellular matrix formation leading to inhibition of mineralization by effects in the early stage of human osteoblast differentiation. J Cell Physiol. 2012;227:2668-2676.

DOI

18
Meyer KD, Jaffrey SR. The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol. 2014;15:313-326.

DOI

19
Li Y, Meng L, Zhao B. The roles of N6-methyladenosine methylation in the regulation of bone development, bone remodeling and osteoporosis. Pharmacol Ther. 2022;238:108174.

DOI

20
Sheng R, Wang Y, Wu Y, et al. METTL3-mediated m6 a mRNA methylation modulates tooth root formation by affecting NFIC translation. J Bone Miner Res. 2021;36:412-423.

DOI

21
Geula S, Moshitch-Moshkovitz S, Dominissini D, et al. Stem cells. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation. Science. 2015;347:1002-1006.

DOI

22
Chen X, Hua W, Huang X, Chen Y, Zhang J, Li G. Regulatory role of RNA N6-Methyladenosine modification in bone biology and osteoporosis. Front Endocrinol (Lausanne). 2019;10:911.

DOI

23
Ma B, Cao P, Zhang L, et al. YTHDC2 inhibits rat bone mesenchymal stem cells osteogenic differentiation by accelerating RUNX2 mRNA degradation via m6A methylation. Heliyon. 2023;9:e18876.

DOI

24
Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell. 2012;149:1635-1646.

DOI

25
Wang X, Zhao BS, Roundtree IA, et al. N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161:1388-1399.

DOI

26
Dominissini D, Moshitch-Moshkovitz S, Schwartz S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201-206.

DOI

27
Yang H, Liang Y, Cao Y, Cao Y, Fan Z. Homeobox C8 inhibited the osteo−/dentinogenic differentiation and migration ability of stem cells of the apical papilla via activating KDM1A. J Cell Physiol. 2020;235:8432-8445.

DOI

28
Cooper GM, Mooney MP, Gosain AK, Campbell PG, Losee JE, Huard J. Testing the critical size in calvarial bone defects: revisiting the concept of a critical-size defect. Plast Reconstr Surg. 2010;125:1685-1692.

DOI

29
Kaur S, Abu-Shahba AG, Paananen RO, et al. Small non-coding RNA landscape of extracellular vesicles from human stem cells. Sci Rep. 2018;8:15503.

DOI

30
Stark A, Brennecke J, Bushati N, Russell RB, Cohen SM. Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3′UTR evolution. Cell. 2005;123:1133-1146.

DOI

31
Sun Q, Liu H, Chen Z. The fine tuning role of microRNA-RNA interaction in odontoblast differentiation and disease. Oral Dis. 2015;21:142-148.

DOI

32
Fang F, Zhang K, Chen Z, Wu B. Noncoding RNAs: new insights into the odontogenic differentiation of dental tissue-derived mesenchymal stem cells. Stem Cell Res Ther. 2019;10:297.

DOI

33
Wu Y-Q, Ding Y-J. Overexpressed microRNA-615-3p promotes progression of neonatal acute respiratory distress syndrome by inhibiting differentiation of mesenchymal stem cells to alveolar type II epithelial cells. Eur Rev Med Pharmacol Sci. 2018;22:4625-4633.

DOI

34
Yin J, Zhuang G, Zhu Y, et al. MiR-615-3p inhibits the osteogenic differentiation of human lumbar ligamentum flavum cells via suppression of osteogenic regulators GDF5 and FOXO1. Cell Biol Int. 2017;41:779-786.

DOI

35
Das Mandal S, Ray PS. Transcriptome-wide analysis reveals spatial correlation between N6-methyladenosine and binding sites of microRNAs and RNA-binding proteins. Genomics. 2021;113:205-216.

DOI

36
Müller S, Bley N, Glaß M, et al. IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors. Nucleic Acids Res. 2018;46:6285-6303.

DOI

37
Busch B, Bley N, Müller S, et al. The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family. Nucleic Acids Res. 2016;44:3845-3864.

DOI

38
Müller S, Glaß M, Singh AK, et al. IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner. Nucleic Acids Res. 2019;47:375-390.

DOI

39
Kong Y, Zhang Y, Cai Y, Li D, Yi B, Xu Q. METTL3 mediates osteoblast apoptosis by regulating endoplasmic reticulum stress during LPS-induced inflammation. Cell Signal. 2022;95:110335.

DOI

40
Li Y, Sheng H, Ma F, et al. RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/β-catenin signaling. Cell Death Dis. 2021;12:479.

DOI

41
Wang X, Lu Z, Gomez A, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117-120.

DOI

42
Liao S, Sun H, Xu C. YTH domain: a family of N6-methyladenosine (m6A) readers. Genomics Proteomics Bioinformatics. 2018;16:99-107.

DOI

43
Lee Y, Choe J, Park OH, Kim YK. Molecular mechanisms driving mRNA degradation by m6A modification. Trends Genet. 2020;36:177-188.

DOI

44
Li J, Chen K, Dong X, et al. YTHDF1 promotes mRNA degradation via YTHDF1-AGO2 interaction and phase separation. Cell Prolif. 2022;55:e13157.

DOI

45
Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019;20:21-37.

DOI

46
Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. 2019;20:5-20.

DOI

47
Chen T, Hao Y-J, Zhang Y, et al. m6A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency. Cell Stem Cell. 2015;16:289-301.

DOI

Options
Outlines

/